NIGER SAYS MILITARY ACTIVITY IN CAPITAL BROUGHT UNDER CONTROL. (PHOTO).

Image
 Niger says military activity in capital brought under control Niger's defense minister said Saturday that military activity in the capital, Niamey, had been brought under control and security forces had regained control of critical sites that were targeted. Gen. Salifou Mody's remarks were broadcast on national television after heavy gunfire and explosions were reported around Diori Hamani International Airport and the presidential palace in Niamey. Mody said a group of soldiers had "broken away from military order" and attempted to detain some of their fellow soldiers at the Base 101 military facility in Niamey before opening fire on several critical sites in the capital. He said the activity was brought under control thanks to the swift intervention of Nigerien defense and security forces, adding that control was gradually restored in the targeted areas. Mody urged residents of Niamey to remain calm and continue their daily activities as usual.

ASTRA-ZENECA FINDS NO EVIDENCE OF INCREASED BLOOD CLOTH RISK FROM VACCINE.{PHOTO}.

 


(Reuters) - AstraZeneca Plc on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine which has shown no evidence of an increased risk of blood clots.

The review covered more than 17 million people vaccinated in the European Union and United Kingdom.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the statement said.

Authorities in Denmark, Norway and Iceland have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders.

Ireland on Sunday temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution”.

The drugmaker said additional testing has and is being conducted by the company and the European health authorities and none of the re-tests have shown cause for concern.

There are also no confirmed issues related to quality of any of its COVID-19 vaccine batches used across Europe and rest of the world, the company said.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.